Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can family power prevent diabetes? trial tests group approach

NCT ID NCT07815236

Prevention Sponsor: Morehouse School of Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing whether adding family health history and family participation to the standard Diabetes Prevention Program helps adults with prediabetes. The trial enrolls 400 adults with prediabetes and a family member who joins them. Participants are assigned to either the family-enhanced program or the standard program. The study measures weight loss, blood sugar changes, and session attendance over 12 months, and also checks whether family members see health benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a family-enhanced Diabetes Prevention Program that adds family health history and family skill-building sessions to the standard behavioral weight loss program
What this could lead to
If it works, this could give diabetes prevention programs a new way to help people by involving family members, potentially improving weight loss and blood sugar for both participants and their relatives.
What could go wrong
This is a mid-stage trial, so results are not guaranteed. Family involvement may not improve outcomes more than the standard program, and participants must attend in-person sessions, which can be hard for some families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jan 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years. * Fasting HbA1c 5.7-6.4% confirmed by CLIA-waived point-of-care testing. * BMI ≥25 kg/m². * Able to provide informed consent. * Has an adult household/family or framily (fictive kin) member willing to enroll as a paired participant. * Willing to attend in-person sessions Exclusion Criteria: * Minors \<18 years * Prior diagnosis of T1 or T2D. * HbA1c ≥6.5% at screening (Aim 1/2 curriculum eligibility) * Current glucose-lowering medication use * Pregnancy * Physical-activity contraindications * Individuals unable to speak or understand English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prediabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome Weight Loss type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prediabetes Weight loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.